Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model
Open Access
- 1 February 2022
- journal article
- research article
- Published by Elsevier in Journal of Traditional and Complementary Medicine
- Vol. 12 (5) , 447-454
Abstract
No abstract availableKeywords
Funding Information
- National Center for Complementary and Alternative Medicine
This publication has 56 references indexed in Scilit:
- Regulation of Foam Cells by AdenosineArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Vascular Contributions to Cognitive Impairment and DementiaStroke, 2011
- Resveratrol (Trans-3,5,4′-trihydroxystilbene) Induces Silent Mating Type Information Regulation-1 and Down-Regulates Nuclear Transcription Factor-κB Activation to Abrogate Dextran Sulfate Sodium-Induced ColitisThe Journal of Pharmacology and Experimental Therapeutics, 2010
- NeurolupusPractical Neurology, 2010
- Neurologic Manifestations of Systemic Lupus Erythematosus in Children and AdultsNeurologic Clinics, 2010
- Different cellular sources and different roles of adenosine: A1 receptor-mediated inhibition through astrocytic-driven volume transmission and synapse-restricted A2A receptor-mediated facilitation of plasticityNeurochemistry International, 2008
- ApoE−/−Fas−/− C57BL/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopeniaJournal of Lipid Research, 2007
- Therapeutic potential of resveratrol: the in vivo evidenceNature Reviews Drug Discovery, 2006
- Genetic interactions between susceptibility loci reveal epistatic pathogenic networks in murine lupusGenes & Immunity, 2003
- Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.Proceedings of the National Academy of Sciences, 1992